|

Corticosteroid Injection Versus Nerve Block

RECRUITINGN/ASponsored by University of Minnesota
Actively Recruiting
PhaseN/A
SponsorUniversity of Minnesota
Started2025-01-02
Est. completion2027-01-02
Eligibility
Age18 Years – 99 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT06735027

Summary

The purpose of this study is to evaluate conservative pain relief measures for patients suffering from glenohumeral arthritis or rotator cuff arthropathy. Conservative management of osteoarthritis is often first line treatment, and while a corticosteroid injection is frequently used, suprascapular nerve blocks have not often been described as an analgesic option in this population.

Eligibility

Age: 18 Years – 99 YearsHealthy volunteers accepted
Inclusion Criteria:

* diagnosis of glenohumeral osteoarthritis, rheumatoid arthritis, or rotator cuff arthropathy who are being offered injection

Exclusion Criteria:

* uncontrolled diabetes (patients will be excluded if no HbA1c within a year or if it is 8 or greater"
* known allergy to steroid or anesthetic
* pregnant women
* prisoners
* patients with diminished capacity to consent to participation
* children under 18 years of age
* non-English speakers

Conditions3

ArthritisGlenohumeral ArthritisRotator Cuff Arthropathy

Locations1 site

University of Minnesota
Minneapolis, Minnesota, 55414
Allison Rao

Browse More Trials

Arthritis trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.